Patents by Inventor Verena Siefke-Henzler

Verena Siefke-Henzler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230028647
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.
    Type: Application
    Filed: May 18, 2022
    Publication date: January 26, 2023
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • Publication number: 20220133890
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: July 2, 2021
    Publication date: May 5, 2022
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • Publication number: 20210038514
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.
    Type: Application
    Filed: July 6, 2020
    Publication date: February 11, 2021
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • Publication number: 20200188516
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: October 28, 2019
    Publication date: June 18, 2020
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • Publication number: 20190142747
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.
    Type: Application
    Filed: February 1, 2019
    Publication date: May 16, 2019
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • Patent number: 10258031
    Abstract: The present invention relates to a recovery assembly for a cooling agent in a cryopreservation device, the recovery assembly comprises a cone-shaped funnel assembly comprising a support for mounting the funnel assembly to an access opening of a container to be at least partially filled with a cooling agent.
    Type: Grant
    Filed: August 5, 2014
    Date of Patent: April 16, 2019
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Petra Arndt, Volker Derdau, Verena Siefke-Henzler
  • Patent number: 10029011
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Grant
    Filed: November 11, 2010
    Date of Patent: July 24, 2018
    Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • Patent number: 10028910
    Abstract: A liquid composition comprising a GLP-1 agonist and/or a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivatives where appropriate.
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: July 24, 2018
    Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • Publication number: 20180200370
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: November 3, 2017
    Publication date: July 19, 2018
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • Publication number: 20170326069
    Abstract: A liquid composition comprising a GLP-1 agonist and/or a pharocoligically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivatives where appropriate.
    Type: Application
    Filed: May 15, 2017
    Publication date: November 16, 2017
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • Patent number: 9707176
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.
    Type: Grant
    Filed: November 11, 2010
    Date of Patent: July 18, 2017
    Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • Publication number: 20160165881
    Abstract: The present invention relates to a recovery assembly for a cooling agent in a cryopreservation device, the recovery assembly comprises a cone-shaped funnel assembly comprising a support for mounting the funnel assembly to an access opening of a container to be at least partially filled with a cooling agent.
    Type: Application
    Filed: August 5, 2014
    Publication date: June 16, 2016
    Inventors: Petra Arndt, Volker Derdau, Verena Siefke-Henzler
  • Publication number: 20160158759
    Abstract: A recovery assembly for a cryopreservation device is presented having a support for mounting the recovery assembly to an access opening of a container to be at least partially filled with the cooling agent, and at least one flow channel to form at least one protective gas stream to reduce escapement of the cooling agent from the container.
    Type: Application
    Filed: August 5, 2014
    Publication date: June 9, 2016
    Inventors: Volker Derdau, Andreas Wolf, Petra Arndt, Verena Siefke-Henzler, Christoph Dette, Ulrike Milbert
  • Publication number: 20120295846
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: November 11, 2010
    Publication date: November 22, 2012
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • Publication number: 20120283179
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.
    Type: Application
    Filed: November 11, 2010
    Publication date: November 8, 2012
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Anette Brunner-Schwarz, Werner Mueller, Verena Siefke-Henzler
  • Publication number: 20120252724
    Abstract: The invention relates to an aqueous pharmaceutical formulation having insulin, an insulin analog, or an insulin derivative, and methionine; and to the production thereof, to the use thereof for treating diabetes mellitus, and to a medication for treating diabetes mellitus.
    Type: Application
    Filed: July 2, 2010
    Publication date: October 4, 2012
    Applicant: SANOFI-AVENTIS
    Inventors: Isabell Schoettle, Annika Hagendorf, Christiane Fuerst, Gerrit Hauck, Verena Siefke-Henzler, Walter Kamm, Julia Schnieders
  • Publication number: 20120232002
    Abstract: Aqueous pharmaceutical formulations with an insulin analog, comprising 0.001 to 0.2 mg/ml of zinc, 0.1 to 5.0 mg/ml of a preservative, and 5.0 to 100 mg/ml of an isotonicity agent, and whose pH is 5 or less, and also their preparation, use for treating diabetes mellitus, and a medicament for treating diabetes mellitus.
    Type: Application
    Filed: July 2, 2010
    Publication date: September 13, 2012
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Isabell Schoettle, Christiane Fuerst, Verena Siefke-Henzler, Gerrit Hauck, Walter Kamm, Julia Schnieders, Jutta Carls, Gert Wolf